Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 016385.KS
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 0.83 1.47 1.46
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 100.00 9.61 0.00
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 6.49 12870.86 12086.57
Cash 100.00 885.67 0.00
Capex 10.66 -93.68 -104.86
Free Cash Flow -88.87 164.86 1481.83
Revenue 9.46 10757.16 9827.75
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 13.89 0.14 0.12
Operating Margin 17.15 0.11 0.10
ROA -5.50 0.02 0.02
ROE -5.04 0.05 0.06
ROIC 19.68 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 016385.KS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 016385.KS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 016385.KS is permitted for members.